TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis is a research paper published in American Journal of Respiratory and Critical Care Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
CHEST Foundation
Grant: Research Grant in Pulmonary Fibrosis
NIH
Grant: K23-HL-150301
NIH
Grant: R01HL162659
NIH
Grant: R01HL171918
NIH
Grant: T32 HL134629
NIH
Grant: T32-HL134629
NIH
Grant: UG3HL145266
NHLBI NIH HHS
Grant: U01 HL128964
NHLBI NIH HHS
Grant: UH3 HL145266
NHLBI NIH HHS
Grant: K23 HL150301
Regeneron Pharmaceuticals
Chiesi
Polarean
Sanofi
Sunovion
Teva Pharmaceutical Industries
GlaxoSmithKline
Novartis
Stony Wold - Herbert Fund
Boehringer Ingelheim
National Heart, Lung, and Blood Institute
Polarean
GlaxoSmithKline
Regeneron Pharmaceuticals
Boehringer Ingelheim
Sunovion
Teva Pharmaceutical Industries
Sanofi
Chiesi
Novartis
Stony Wold - Herbert Fund
FWCI
2.50
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords